← Leaderboards
Michael L Gatza
Duke University
$996,774
Attributed
$996,774
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2009–17$250K$187.5K$125K$62.5K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$996,774 · 3
By mechanism
R00$747,000 · 1
K99$199,720 · 1
F32$50,054 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Robert M Califf$60,661,909
- Michael Barry Kastan$65,974,699
- Herbert Kim Lyerly$48,598,090
- Andrew J Armstrong$4,232,419
- Marianne Hamilton Lopez$9,528,155
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResistanceGenomicsMalignant Breast NeoplasmPathway InteractionsPharmaceutical PreparationsExhibitsGenesInsightLaboratoriesNew Therapeutic TargetOncogenicBasePatternCollectionCancer PatientCancer TherapyGene Expression ProfileCharacteristicsHeterogeneityInvestigationIn VivoMutationResponse
Grant awards (6)
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer$249,000
R00 · FY2017 · CA · contact PI
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer$249,000
R00 · FY2016 · CA · contact PI
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer$249,000
R00 · FY2015 · CA · contact PI
A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer$99,860
K99 · FY2014 · CA · contact PI
A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer$99,860
K99 · FY2013 · CA · contact PI
Use of Genomic Signatures to Classify Tumors and Direct Chemotherapeutics$50,054
F32 · FY2009 · CA · contact PI